{"url_path":"/sec/pmvp/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1699382/0001193125-26-218227-index.html","accession_number":"0001193125-26-218227","cik":"0001699382","ticker":"PMVP","issuer_name":"PMV Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1699382/0001193125-26-218227-index.html","primary_entity_key":"0001699382","primary_entity_name":"PMV Pharmaceuticals, Inc."},"word_count":87,"has_tables":true,"body_markdown":"Item 1A. Risk Factors.\n\nThere have been no material changes to the Company’s risk factors as set forth in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC on March 6, 2026, which are hereby incorporated by reference. You should carefully review and consider the information regarding such risk factors and the risks and uncertainties described elsewhere in this report which could materially affect our business, financial condition or future prospects."}